Total Payments
$789.10
2024 Payments
$73.08
Companies
15
Transactions
48
Medicare Patients
1,819
Medicare Billing
$192,927
Payment Breakdown by Category
Food & Beverage$789.10 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $789.10 | 48 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $204.67 | 13 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $141.87 | 9 | $0 (2022) |
| ABBVIE INC. | $86.72 | 6 | $0 (2024) |
| Philips Electronics North America Corporation | $70.55 | 4 | $0 (2023) |
| Grifols USA, LLC | $51.34 | 3 | $0 (2022) |
| BTG International, Inc. | $46.93 | 3 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $38.31 | 2 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $22.26 | 1 | $0 (2022) |
| CSL Behring | $21.53 | 1 | $0 (2018) |
| Ethicon US, LLC | $21.18 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $73.08 | 4 | PFIZER INC. ($34.94) |
| 2023 | $152.94 | 8 | Philips Electronics North America Corporation ($53.58) |
| 2022 | $156.48 | 9 | Grifols USA, LLC ($36.76) |
| 2021 | $133.28 | 9 | AbbVie Inc. ($50.71) |
| 2020 | $85.52 | 6 | Janssen Pharmaceuticals, Inc ($39.95) |
| 2019 | $68.62 | 4 | PFIZER INC. ($37.46) |
| 2018 | $93.95 | 6 | PFIZER INC. ($41.94) |
| 2017 | $25.23 | 2 | PFIZER INC. ($13.31) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/09/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $19.74 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/30/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT, ZAVZPRET | Food and Beverage | In-kind items and services | $15.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/10/2024 | Philips North America LLC | (CM9) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $18.90 | General |
| Category: Medical Device | ||||||
| 01/10/2024 | ABBVIE INC. | TEFLARO (Drug), DALVANCE | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/14/2023 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ANTI-INFECTIVE | ||||||
| 10/16/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $22.56 | General |
| Category: Cardiovascular | ||||||
| 10/12/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $17.47 | General |
| Category: Medical Device | ||||||
| 06/21/2023 | Ethicon US, LLC | DERMABOND (Device), STRATAFIX | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Wound Closure | ||||||
| 05/10/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: Medical Device | ||||||
| 05/08/2023 | BTG International, Inc. | DIGIFAB (Drug) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Toxicity Antidote (Digoxin Toxicity) | ||||||
| 01/31/2023 | Inari Medical, Inc. | FLOWTRIEVER CATHETER, S (Device), CT THROMBECTOMY SYSTEM KIT | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: VTE | ||||||
| 01/12/2023 | Philips Electronics North America Corporation | (5091) Amb Mon & Diag Und (Device) | Food and Beverage | Cash or cash equivalent | $19.03 | General |
| Category: Medical Device | ||||||
| 12/20/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.88 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/29/2022 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Immunology | ||||||
| 09/23/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $16.97 | General |
| Category: Medical Device | ||||||
| 08/10/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $15.16 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/09/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2022 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/02/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Cardiovascular | ||||||
| 03/07/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/03/2022 | Grifols USA, LLC | HyperRAB (Biological) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Immunology | ||||||
| 12/07/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/17/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/04/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.59 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/08/2021 | AbbVie Inc. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $11.65 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 492 | 501 | $192,241 | $53,199 |
| 2022 | 4 | 438 | 441 | $161,344 | $38,718 |
| 2021 | 3 | 411 | 426 | $114,575 | $49,785 |
| 2020 | 3 | 478 | 496 | $118,825 | $51,225 |
Total Patients
1,819
Total Services
1,864
Medicare Billing
$192,927
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 292 | 300 | $138,436 | $38,310 | 27.7% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 140 | 141 | $43,005 | $11,869 | 27.6% |
| 99283 | Emergency department visit with low level of medical decision making | Facility | 2023 | 60 | 60 | $10,800 | $3,021 | 28.0% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 179 | 182 | $94,610 | $22,800 | 24.1% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 109 | 109 | $41,877 | $8,923 | 21.3% |
| 99283 | Emergency department visit for problem of moderate severity | Facility | 2022 | 108 | 108 | $20,447 | $5,666 | 27.7% |
| 99282 | Emergency department visit for problem of mild to moderate severity | Facility | 2022 | 42 | 42 | $4,410 | $1,328 | 30.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2021 | 235 | 245 | $76,100 | $33,835 | 44.5% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2021 | 146 | 151 | $33,975 | $14,289 | 42.1% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2021 | 30 | 30 | $4,500 | $1,661 | 36.9% |
| 99284 | Emergency department visit, problem of high severity | Facility | 2020 | 355 | 373 | $83,925 | $35,316 | 42.1% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 94 | 94 | $30,550 | $14,437 | 47.3% |
| 99283 | Emergency department visit, moderately severe problem | Facility | 2020 | 29 | 29 | $4,350 | $1,471 | 33.8% |
About Dr. Hugh Davis, MD
Dr. Hugh Davis, MD is a Emergency Medical Services healthcare provider based in Dothan, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770540775.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Hugh Davis, MD has received a total of $789.10 in payments from pharmaceutical and medical device companies, with $73.08 received in 2024. These payments were reported across 48 transactions from 15 companies. The most common payment nature is "Food and Beverage" ($789.10).
As a Medicare-enrolled provider, Davis has provided services to 1,819 Medicare beneficiaries, totaling 1,864 services with total Medicare billing of $192,927. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Emergency Medical Services
- Location Dothan, AL
- Active Since 04/26/2006
- Last Updated 07/08/2007
- Taxonomy Code 207PE0004X
- Entity Type Individual
- NPI Number 1770540775
Products in Payments
- ELIQUIS (Drug) $201.04
- XARELTO (Drug) $141.87
- DALVANCE (Drug) $84.06
- (5091) Amb Mon & Diag Und (Device) $53.58
- CHANTIX (Drug) $41.94
- HyperRAB (Biological) $36.76
- LOKELMA (Drug) $22.26
- Kcentra (Biological) $21.53
- DERMABOND (Device) $21.18
- DIGIFAB (Drug) $19.47
- FLOWTRIEVER CATHETER, S (Device) $19.38
- TEFLARO (Drug) $19.24
- (CM9) Amb Mon & Diag Und (Device) $18.90
- (5044) MCOT (Device) $16.97
- GENERAL - KIDNEY STONE DISEASE (Device) $16.96
- CroFab (Drug) $15.91
- HyperRAB SD (Biological) $14.58
- Activase (Biological) $11.92
- CROFAB (Drug) $11.55
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.